Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Cr.3O |
| Molecular Weight | 151.9904 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[O--].[O--].[Cr+3].[Cr+3]
InChI
InChIKey=UOUJSJZBMCDAEU-UHFFFAOYSA-N
InChI=1S/2Cr.3O/q2*+3;3*-2
| Molecular Formula | Cr |
| Molecular Weight | 51.9961 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0004714 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15924436 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | CHROMIUM Approved UseChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. Launch Date2005 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment. | 2017-09-21 |
|
| Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats. | 2007-11 |
|
| Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. | 2007-10 |
|
| Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. | 2007-08 |
|
| The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. | 2005-12-01 |
|
| Status of antioxidant defense system in chromium-induced Swiss mice tissues. | 2004-07 |
|
| Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate. | 1999-12 |
|
| Activation of MAPKs in human bronchial epithelial cells exposed to metals. | 1998-09 |
|
| Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. | 1996-03 |
|
| Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. | 1994-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:36:10 GMT 2025
by
admin
on
Mon Mar 31 18:36:10 GMT 2025
|
| Record UNII |
X5Z09SU859
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 178.3297
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
||
|
EPA PESTICIDE CODE |
21103
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
||
|
CFR |
21 CFR 177.2600
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
||
|
CFR |
21 CFR 177.1520
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
215-160-9
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
X5Z09SU859
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
DTXSID4043721
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
300000053124
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
48240
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
1308-38-9
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
m3508
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
1619
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
48242
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
X5Z09SU859
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
C023600
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
Chromium(III) oxide
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY | |||
|
165971
Created by
admin on Mon Mar 31 18:36:10 GMT 2025 , Edited by admin on Mon Mar 31 18:36:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |